Peanut allergy rates in toddlers fall 43% in last decade
New research suggests that introducing peanut products to infants between four and six months of age is a key driver of the decline.
By Fiona Wallace ·
A decade of shifting dietary advice for infants has produced a measurable drop in childhood peanut allergies, with rates for children under three falling by roughly 43% since 2015.
The data, released in October 2025, aligns with new studies indicating that introducing peanut products to babies between four and six months of age significantly reduces the risk of developing an allergy.
This finding challenges long-held medical guidance that recommended avoiding peanuts for young children, a strategy that experts now view as counterproductive.
The decline offers a concrete outcome for parents who have followed updated protocols for early food introduction, providing a statistical baseline for the efficacy of the new approach.
Separate coverage within the same health briefing addressed the intersection of aging and intimacy, focusing on how physical changes affect relationships.
Sam Cradduck, a gerontologist, emphasized that the initial step for couples facing these changes is to identify the specific cause of the shift.
She stated that competence and consent are the primary factors to consider when evaluating the situation.
Dr. Rhea Rogers, a board-certified physician, noted that physical issues such as erectile dysfunction are often manageable with medical intervention.
Rogers also pointed out a common misconception among couples, who frequently treat intimacy and sexuality as interchangeable concepts when they are distinct experiences.
The discussion extended to the role of older adults in clinical research, a demographic that remains frequently underrepresented in trial data.
Rogers advised that prospective participants should first understand what specific question a clinical trial is designed to answer.
She highlighted the benefit of access, noting that participants gain early entry to therapies and devices that may not be available to the general public for years. "You get great access to tomorrow’s medicines today, devices, therapies and other things that will not be available to everybody else for years," Rogers said. Aging expert Amy O’Rourke added that participants must understand they may receive a placebo during the study. Beyond clinical data, the segment featured Flo Meiler, a 91-year-old resident of Vermont who holds two world records in track and field. Meiler began competing in the sport at age 60 and continues to compete at her current age. She described her ongoing participation as a source of joy, despite physical limitations. "I’m sad that I can’t jump like I used to, but I really enjoy it," Meiler said. Her home contains a collection of medals from her competitive career, serving as a record of her sustained activity well into her ninth decade. The program, which provides educational and informational content, notes that the information shared should not replace professional medical advice from a licensed physician.
Source: KAUU
